Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$2.29
-0.0600 (-2.55%)
At Close: May 10, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $1.66 $2.47 Friday, 10th May 2024 PTN stock ended at $2.29. This is 2.55% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 11.76% from a day low at $2.21 to a day high of $2.47.
90 days $1.47 $4.65
52 weeks $1.43 $5.65

Historical Palatin Technologies Inc prices

Date Open High Low Close Volume
Sep 15, 2016 $0.550 $0.550 $0.540 $0.541 518 600
Sep 14, 2016 $0.532 $0.555 $0.532 $0.540 710 700
Sep 13, 2016 $0.560 $0.580 $0.522 $0.543 783 700
Sep 12, 2016 $0.570 $0.580 $0.541 $0.550 1 247 700
Sep 09, 2016 $0.630 $0.631 $0.541 $0.564 3 136 100
Sep 08, 2016 $0.520 $0.610 $0.510 $0.599 4 981 900
Sep 07, 2016 $0.530 $0.530 $0.500 $0.508 543 000
Sep 06, 2016 $0.500 $0.530 $0.500 $0.505 657 700
Sep 02, 2016 $0.510 $0.510 $0.500 $0.505 568 000
Sep 01, 2016 $0.519 $0.519 $0.500 $0.500 403 800
Aug 31, 2016 $0.510 $0.520 $0.498 $0.510 448 300
Aug 30, 2016 $0.520 $0.530 $0.500 $0.500 446 200
Aug 29, 2016 $0.503 $0.529 $0.500 $0.520 348 000
Aug 26, 2016 $0.490 $0.508 $0.490 $0.500 426 300
Aug 25, 2016 $0.529 $0.530 $0.480 $0.481 1 211 400
Aug 24, 2016 $0.540 $0.548 $0.504 $0.525 1 216 200
Aug 23, 2016 $0.520 $0.539 $0.520 $0.530 729 700
Aug 22, 2016 $0.520 $0.550 $0.511 $0.530 1 250 600
Aug 19, 2016 $0.510 $0.520 $0.502 $0.518 293 500
Aug 18, 2016 $0.495 $0.532 $0.495 $0.509 1 123 700
Aug 17, 2016 $0.536 $0.540 $0.510 $0.522 847 000
Aug 16, 2016 $0.520 $0.539 $0.510 $0.524 862 300
Aug 15, 2016 $0.550 $0.580 $0.491 $0.520 1 628 900
Aug 12, 2016 $0.580 $0.580 $0.550 $0.550 1 279 200
Aug 11, 2016 $0.600 $0.600 $0.560 $0.560 1 270 200
Click to get the best stock tips daily for free!

About Palatin Technologies Inc

Palatin Technologies Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatmen... PTN Profile

Golden Star

Ticker Date Change Price
SXI May 08 2.97% $173.34
NVO May 08 1.37% $126.69
PAG May 07 1.42% $153.22
WMT May 06 1.02% $59.87
UNP May 06 3.42% $239.21
JPM May 06 3.53% $192.00
INGR May 03 4.94% $114.56
ASH May 03 2.28% $95.85
INVH May 03 1.13% $34.39
INTU May 03 0.483% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT